1. Medtech Insight

MedRhythms On First-To-Market Track With Prescription Music Therapy For Chronic Stroke

 
• By Marion Webb

MedRhythms’ digital therapeutics platform aims to improve walking and functional outcomes in patients with multiple sclerosis, Parkinsons’ disease and chronic stroke. With around $32m in funding to date, the start-up boasts collaborations with major medical centers and a partnership with Biogen.

Music therapy
• Source: Shutterstock

Portland, Maine-based MedRhythms aims to be first to market in 2023 with a prescription digital therapeutic to treat walking deficits in chronic stroke patients, pending regulatory clearance.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight